Key result
OCT-guided sirolimus DCB yields vessel healing and symptom relief in spontaneous recanalized coronary thrombus.
Why the study?
Spontaneous recanalized coronary thrombus is an uncommon, underrecognized pathology, and optimal treatment strategies remain incompletely defined.
Does OCT-guided sirolimus-coated drug-coated-balloon angioplasty improve lumen gain and symptoms in a patient with spontaneously recanalized coronary thrombus?
Does OCT-guided sirolimus-coated drug-coated-balloon angioplasty improve lumen gain and symptoms in a patient with spontaneously recanalized coronary thrombus?
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“OCT-guided drug-coated-balloon angioplasty may be an effective 'leave-nothing-behind' strategy for selected SRCT lesions, highlighting the importance of intracoronary imaging beyond angiography.”
“It is on intracoronary imaging-guided 'leave-nothing-behind' strategies that may be effective in selected cases.”
OCT-guided sirolimus-coated drug-coated-balloon angioplasty may be an effective 'leave-nothing-behind' strategy for managing spontaneously recanalized coronary thrombus.
Background: Spontaneous recanalized coronary thrombus (SRCT) is an uncommon and often underrecognized coronary pathology that may be angiographically subtle despite having functional significance. Optical coherence tomography (OCT) enables accurate diagnosis and treatment planning. However, optimal treatment strategies remain incompletely defined. Materials and Methods: A 55-year-old man presenting with severe exertional dyspnea, atypical chest pain episodes, and abnormal stress echocardiography underwent invasive coronary assessment with angiography, fractional flow reserve (FFR), and OCT. An SRCT of the left anterior descending artery (LAD) was identified and treated using OCT-guided lesion preparation followed by sirolimus-coated drug-coated-balloon (DCB) angioplasty. Results: Although there was only moderate angiographic disease, a functional assessment confirmed significant ischemia. OCT revealed a characteristic honeycomb morphology. Post-procedural OCT demonstrated satisfactory lumen gain, with preserved vessel integrity. Follow-up imaging showed vessel-healing and late lumen enlargement, and the patient remained asymptomatic. Conclusion: OCT-guided drug-coated-balloon angioplasty may be an effective “leave-nothing-behind” strategy for selected SRCT lesions, highlighting the importance of intracoronary imaging beyond angiography.
Erdogan et al. (2026) studied this question. OCT-guided sirolimus-coated drug-coated balloon angioplasty effectively treated spontaneous recanalized coronary thrombus with vessel healing and symptom relief.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: